FROM THE ARCHIVE
Research: Drugs may help diabetics
Facebook
Twitter
Email
THURSDAY, SEPTEMBER 20, 2001 Research published in today's issue of The New England Journal of Medicine suggests that a new class of drugs already used to fight high blood pressure can help reduce the risk of kidney damage in type 2 diabetics. In three studies, diabetics were given the drugs, called called angiotensin receptor blocking agents (ARBs). The drugs reduced the risk of developing kidney problems and in one case, they protected patients in early stages of kidney failure. Type 2 diabetes is affecting an increasing number of Native Americans, with some tribes experiencing rates as high as 50 percent among adults. Diabetes is showing up earlier in young Natives as well. Get the Story:
New Drugs May Reduce Kidney Risk in Diabetics (The Washington Post 9/20) Relevant Links:
The New England Journal of Medicine - http://www.nejm.org Related Stories:
Clinic fights diabetes with tradition (9/19)
Advertisement
Stay Connected
Contact
Search
Trending in News
1 White House Council on Native American Affairs meets quick demise under Donald Trump
2 'A process of reconnecting': Young Lakota actor finds ways to stay tied to tribal culture
3 Jenni Monet: Bureau of Indian Affairs officer on leave after fatal shooting of Brandon Laducer
4 'A disgraceful insult': Joe Biden campaign calls out Navajo leader for Republican speech
5 Kaiser Health News: Sisters from Navajo Nation died after helping coronavirus patients
2 'A process of reconnecting': Young Lakota actor finds ways to stay tied to tribal culture
3 Jenni Monet: Bureau of Indian Affairs officer on leave after fatal shooting of Brandon Laducer
4 'A disgraceful insult': Joe Biden campaign calls out Navajo leader for Republican speech
5 Kaiser Health News: Sisters from Navajo Nation died after helping coronavirus patients
News Archive
About This Page
You are enjoying stories from the Indianz.Com Archive, a collection dating back to 2000. Some outgoing links may no longer work due to age.
All stories are available for publishing via Creative Commons License: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)